US pediatrician group recommends Covid vaccines for kids Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T Wed Th F 20 August, 2025

Big Pharma is doubling down. Startups are going all in. Who’s actually making AI work in drug R&D? Join the debate — online in the morning for everyone and in person for live-only content and a reception in the evening at NYC’s Georgia Room. Choose your pass today.

spotlight George Church’s lab gets closer to creating human eggs in a dish, and a new startup plans to finish the job

news Celldex shelves antibody in swallowing disorder, looks to itching readouts next year Catalent lays off 350 workers over change in demand from a ‘large customer’  American Academy of Pediatrics breaks with RFK, CDC on Covid vaccines for kids

Aug 21 2:00pm ET Agentic AI is here: Real-world applications in life sciences & healthcare sponsored by IBM Sep 04 11:00am ET Not just a tool: How AI agents become trial teammates sponsored by Medable Sep 09 11:30pm ET How ctDNA can assist in critical nonoperative management decisions sponsored by Haystack MRD Sep 25 11:00am ET Leveraging acoustic focusing for fast and precise high-parameter flow cytometry panels sponsored by Thermo Fisher

Biopharma is grappling with diverging policies between the US, EU, and Asia — including proposed drug pricing reforms in the US and new EU regulations taking effect this year. The need for strategic clarity has never been more urgent. Join us in London — in person and virtually — where we’re bringing together the industry’s most influential voices to chart a path forward.

endpoints pharma HHS says ‘the science speaks for itself’ on mRNA cuts. Some of the scientists it cites disagree FDA rejects PTC's Friedreich’s ataxia drug HHS seeks to dismiss Rhode Island lawsuit over reorganization plans Irish pharma exports to the US decrease after months of stockpiling

in case you missed it 1. Updated: Viking’s stock tanks as mid-stage obesity pill disappoints on efficacy, safety 2. CSL to spin out flu vaccine business, trim workforce in expansive overhaul 3. Exclusive: Sensorium raises $25M to test succulent-derived drug for anxiety 4. Roivant-backed VantAI and Halda line up $1B RIPTAC pact 5. News Briefing BiomX’s mid-stage cystic fibrosis trial put on clinical hold; Santen makes a deal with RemeGen 6. FDA delays decision on Regenxbio’s Hunter syndrome gene therapy by three months 7.